Latest Updates on Lipid Management

Autoři	EGOM Emmanuel Eroume-A. PHARITHI Rebabonye B. HESSE Soressa STARR Neasa ARMSTRONG Richard SULAIMAN Habitha Mohammed GAZDIKOVA Katarina MOZOS Ioana CAPRNDA Martin KUBATKA Peter KRUŽLIAK Peter KHAN Barkat GASPAR Ludovit MAHER Vincent M. G.
Rok publikování	2019
Druh	Článek v odborném periodiku
Časopis / Zdroj	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
www	http://dx.doi.org/10.1007/s40292-019-00306-8
Doi	http://dx.doi.org/10.1007/s40292-019-00306-8
Klíčová slova	ASCVD; Atherosclerotic cardiovascular disease; Cholesterol; Lipid management; Triglycerides
Popis	Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.